| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 09.02.
| Teva UK introduces generic Glaucoma drops | | 7 | Pharma Bus Review |
| 08.02.
| Bernstein: Teva has upside potential | | 20 | Globes |
| 08.02.
| Teva UK Limited Launches Latanoprost + Timolol Eye Drops | | 61 | PR Newswire |
| CASTLEFORD, England, February 8, 2012 /PRNewswire/ --
We are pleased to announce the launch of Latanoprost + Timolol 0.05mg/ml + 5mg/ml Eye Drops.
It is indicated in the treatment of the reduction...
Mehr lesen zu:
Teva UK Limited Launches Latanoprost + Timolol Eye Drops | |
| 07.02.
| Teva veterinary products unit resumes production | | 13 | Globes |
| 06.02.
| Teva Invests In Immuno-Therapy For Deadly Cancer Research | | 7 | Seeking Alpha |
| 06.02.
| Teva Downgraded: Upside Looks Limited | | 13 | Barron's |
| 06.02.
| 2 Biotechs On Teva's Radar Screen | | 15 | Seeking Alpha |
| 06.02.
| Morgan Stanley stuft Teva Pharma von Overweight auf Equal Weight ab. | | 124 | BörseGo |
| Morgan Stanley stuft Teva Pharma von Overweight auf Equal Weight ab.
(© BörseGo AG 2012 - Autor: Thomas Gansneder, Redakteur)
Mehr lesen zu:
Morgan Stanley stuft Teva Pharma von Overweight auf Equal Weight ab. | |
| 06.02.
| Teva faces further NIS 200m tax bill | | 5 | Globes |
| 01.02.
| Checking the Quality of Teva's Growth | | 24 | Motley Fool |
| 01.02.
| Teva CEO Change Stokes Best January Since "97: Israel Overnight | | 15 | Business Week |
| 30.01.
| Teva Pharmaceutical's Dividend X-Ray | | 36 | Motley Fool |
| 29.01.
| Teva eyes $2b Indian acquisition - report | | 25 | Globes |
| 29.01.
| Teva Declines the Most in a Month on Competition, Recall: Tel Aviv Mover | | 5 | Bloomberg |
| 26.01.
| Teva Partnership And Pipeline Potential: Why Antares Is A Buy | | 21 | Seeking Alpha |
| 26.01.
| Teva raises investment in cell therapy co | | 13 | Globes |
| 26.01.
| Zacks Bull and Bear of the Day Highlights: DaVita, Hhgregg, Mylan, Teva Pharmaceutical and Novartis | | 70 | PR Newswire |
| CHICAGO, Jan. 25, 2012 /PRNewswire/ --Zacks Equity Research highlights DaVita, Inc. (NYSE: DVA) as the Bull of the Day and Hhgregg, Inc. (NYSE: HGG) as the Bear of the Day. In addition, Zacks Equity...
Mehr lesen zu:
Zacks Bull and Bear of the Day Highlights: DaVita, Hhgregg, Mylan, Teva Pharmaceutical and Novartis | |
| 24.01.
| Teva Pharmaceutical Industries Management Presents at 30th Annual J.P. Morgan Healthcare Conference (Transcript) | | 13 | Seeking Alpha |
| 23.01.
| Teva Rises to Eight-Month High on Novartis News: Tel Aviv Mover | | 27 | Business Week |
| 22.01.
| Sun: Teva rises | | 11 | Globes |
